HPLC-MS-MS quantification of short-chain fatty acids actively secreted by probiotic strains
Frontiers in Microbiology · 03.03.2023 · 14
DOI: 10.3389/fmicb.2023.1124144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 03.03.2023. Verfasst von Marco Calvigioni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi.
Abstract (Originalsprache)
Introduction
Short-chain fatty acids (SCFAs) are the main by-products of microbial fermentations occurring in the human intestine and are directly involved in the host’s physiological balance. As impaired gut concentrations of acetic, propionic, and butyric acids are often associated with systemic disorders, the administration of SCFA-producing microorganisms has been suggested as attractive approach to solve symptoms related to SCFA deficiency.
Methods
In this research, nine probiotic strains ( Bacillus clausii NR, OC, SIN, and T, Bacillus coagulans ATCC 7050, Bifidobacterium breve DSM 16604, Limosilactobacillus reuteri DSM 17938, Lacticaseibacillus rhamnosus ATCC 53103, and Saccharomyces boulardii CNCM I-745) commonly included in commercial formulations were tested for their ability to secrete SCFAs by using an improved protocol in high-performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS-MS).
Results
The developed method was highly sensitive and specific, showing excellent limits of detection and quantification of secreted SCFAs. All tested microorganisms were shown to secrete acetic acid, with only B. clausii and S. boulardii additionally able to produce propionic and butyric acids. Quantitative differences in the secretion of SCFAs were also evidenced.
Discussion
The experimental approach described in this study may contribute to the characterization of probiotics as SCFA-producing organisms, a crucial stage toward their application to improve SCFA deficiency.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
- Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
- Research Center Nutraceuticals and Food for Health-Nutrafood, University of Pisa, Pisa, Italy.
Förderung
- Sanofi
Zitieren
APA
Calvigioni, M., Bertolini, A., Codini, S., Mazzantini, D., Panattoni, A., Massimino, M., Celandroni, F., Zucchi, R., Saba, A., & Ghelardi, E. (2023). HPLC-MS-MS quantification of short-chain fatty acids actively secreted by probiotic strains. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1124144
Vancouver
Calvigioni M, Bertolini A, Codini S, Mazzantini D, Panattoni A, Massimino M, et al. HPLC-MS-MS quantification of short-chain fatty acids actively secreted by probiotic strains. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1124144
BibTeX
@article{Calvigioni2023,
author = {Calvigioni, Marco and Bertolini, Andrea and Codini, Simone and Mazzantini, Diletta and Panattoni, Adelaide and Massimino, Mariacristina and Celandroni, Francesco and Zucchi, Riccardo and Saba, Alessandro and Ghelardi, Emilia},
title = {HPLC-MS-MS quantification of short-chain fatty acids actively secreted by probiotic strains},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1124144}
}
EUVIMED